COMPANY PROFILE

KÄÄPÄ BioTech

Explore full profile

Bringing mushroom and fungi inventions to the market

Raseborg, FinlandFounded 2018Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About KÄÄPÄ BioTech

Kaapa Biotech is a biotechnology company focused on creating healthier humans and ecosystems through innovative solutions involving fungi. The company operates primarily in the nutraceutical and food supplement industry, providing high-quality medicinal mushroom ingredients. Kaapa Biotech serves clients ranging from nutraceutical companies to food supplement manufacturers, offering them sustainable and responsibly sourced mushroom products. The company has been recognized for its commitment to sustainability and innovation, winning the Start-up Award at the NutraIngredients Awards 2021. Kaapa Biotech's business model revolves around researching, developing, and wholesaling medicinal mushroom ingredients, particularly chaga, through its extensive cultivation network. Revenue is generated through the sale of these ingredients to various nutraceutical and food supplement companies.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Raseborg, Finland
Employees: 35
Open positions: None listed
Dealroom signal: 85.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Investment activity: 1 company, latest Aug 2023
Capital deployed: $0
Preferred round: Unknown
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Open roles

1 open role

Production PlannerOperations · Karjalohja, Finland · 2mo ago

From job postings in the last four months.More startups hiring →

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Nov 2025	$9.9M	$40M	ZINTINUS · PeakBridge	↗
EARLY VC✓Equity / VC	Apr 2025	$990K	$4M	PeakBridge	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	Profit	Margin
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

KÄÄPÄ BioTech website traffic

Latest recorded traffic for KÄÄPÄ BioTech is 670 monthly website visits, down 58.1% over the last three months. KÄÄPÄ BioTech's team grew 52.2% over the past year.

Latest monthly visits670 3-month web change-58.1% 1-year team growth+52.2%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Operations Development & Scale-up ManagerKarjalohja, Uusimaa, Finland · Business Development · Aug 31, 2026 ERP & Master Data SpecialistKarjalohja, Uusimaa, Finland · Data Science & Engineering · Aug 31, 2026 Production PlannerKarjalohja, Uusimaa, Finland · Project Management · Aug 23, 2026

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LELeadscopeAccess to research data	Dublin, United States	Acquired	—	$7M	—
WEWellMetrisHealth and wellness screening platform	United States	Operational
QDQuotient DiagnosticsDevelops a testing technology for the diagnosis, treatment, and management of diabetes and associated diseases	Penicuik, United Kingdom	Acquired
CLCLEWPredictive clinical analytics that ICU and high-acuity staff and management can use to avoid deteriorations	Netanya, Israel	Operational
DMData MATRIXData Matrix's products automate the processes of clinical trials, while users can manage and monitor its progress online	Saint Petersburg, Russia	Operational
CUCureJoyPlatform that provides reliable information on alternative and holistic healthcare from the experts in the field	San Francisco, United States	Operational
SLSteep Hill LabsGlobal leader in cannabis testing and analytics \| CA \| CO \| NV \| WA \| Phone: +1 (800) 658-0955 \| Email: [email protected]	Berkeley, United States	Operational
ATAirstrip TechnologiesImproves healthcare delivery with mobile interoperability	San Antonio, United States	Operational